News

Questions? Please ask the press team.

To press contacs
All news
Corporate
Brands
Sports
R&D

Dr. August Wolff and Cantabria Labs enter into an exclusive commercialization agreement for Southern Europe for hyperhidrosis product

Read more
13.04.2021

Dr. August Wolff and Cantabria Labs enter into an exclusive commercialization agreement for Southern Europe for hyperhidrosis product

Promising German-Spanish partnership between Dr. August Wolff GmbH & Co. KG Arzneimittel and Cantabria Labs officially sealed.

Read more

Dr. August Wolff Submits Application for Marketing Authorization of 1% Glycopyrronium Bromide (GPB) Cream in the EU – Positive Phase 3a Part of Pivotal Study Results for 1% GPB Cream in Patients with Primary Axillary Hyperhidrosis

Read more
22.03.2021

Dr. August Wolff Submits Application for Marketing Authorization of 1% Glycopyrronium Bromide (GPB) Cream in the EU – Positive Phase 3a Part of Pivotal Study Results for 1% GPB Cream in Patients with Primary Axillary Hyperhidrosis

The Bielefeld-based family-owned pharmaceutical developing and manufacturing company Dr. August Wolff GmbH & Co. KG Arzneimittel (“Dr. August Wolff”) announces that the “Marketing Authorisation Application” (MAA) for 1% Glycopyrronium bromide (GPB) cream was submitted on February 26th to the Medical Products Agency (MPA, Sweden) despite the challenges of the COVID-19 pandemic.

Read more

First medical anti-COVID-19 mouth and throat wash with laboratory and clinical data

Read more
25.02.2021

First medical anti-COVID-19 mouth and throat wash with laboratory and clinical data

Based on their know-how in the field of oral hygiene, Dr. Wolff presents with Linola® sept mouth and throat wash for the first time a product, which has been confirmed in its corona prophylaxis in several laboratory and additional clinical test results.

Read more